Q1 2022 Holdings
Filed 2022-05-16 | 47 holdings | $213.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $59.4M | 1,615,000 | 27.9% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $50.9M | 3,011,352 | 23.9% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $41.7M | 950,000 | 19.6% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $28.9M | 1,500,000 | 13.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $20.5M | 175,000 | 9.6% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $6.9M | 550,259 | 3.3% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.1M | 200,000 | 1.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.1M | 150,000 | 0.5% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $892.0K | 200,000 | 0.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $45.7K | 900,000 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $45.2K | 2,797,501 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $44.5K | 475,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $43.3K | 1,250,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $43.1K | 340,000 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $34.1K | 2,514,280 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $31.9K | 2,850,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $30.3K | 1,800,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $28.8K | 350,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $26.8K | 1,614,021 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $26.5K | 1,385,251 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $26.4K | 2,734,392 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $23.7K | 1,000,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $16.7K | 1,000,000 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $15.9K | 3,743,875 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $9.7K | 717,285 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $9.5K | 1,400,000 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $9.0K | 385,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $8.7K | 675,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $7.4K | 300,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.1K | 454,545 | 0.0% |
| Instil BIO Inc | COM | 45783C101 | $4.1K | 377,091 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $3.0K | 306,236 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $2.7K | 252,726 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $2.2K | 96,912 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $2.1K | 213,744 | 0.0% |
| Spruce Biosciences Inc | COM | 85209E109 | $2.0K | 1,000,000 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $1.9K | 134,650 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $1.5K | 412,837 | 0.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.5K | 300,000 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $1.4K | 205,595 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $1.2K | 1,000,000 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $1.2K | 286,652 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $1.1K | 178,281 | 0.0% |
| Somalogic Inc(SLGCUSD) | CLASS A COM | 83444K105 | $802 | 100,000 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $680 | 134,194 | 0.0% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $81 | 12,986 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $54 | 66,666 | 0.0% |